FRMD8 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.998600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.900300E-02
Normal-vs-Stage2
9.669000E-01
Normal-vs-Stage3
2.606400E-01
Normal-vs-Stage4
3.475800E-01
Stage1-vs-Stage2
8.411600E-04
Stage1-vs-Stage3
6.697800E-01
Stage1-vs-Stage4
8.028300E-02
Stage2-vs-Stage3
8.066100E-02
Stage2-vs-Stage4
4.255800E-02
Stage3-vs-Stage4
3.664800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.491000E-01
Normal-vs-AfricanAmerican
6.203800E-01
Normal-vs-Asian
9.628000E-01
Caucasian-vs-AfricanAmerican
2.273000E-01
Caucasian-vs-Asian
8.079400E-01
AfricanAmerican-vs-Asian
4.865200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.294800E-01
Normal-vs-Female
9.605000E-01
Male-vs-Female
5.324000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.569400E-01
Normal-vs-Age(41-60Yrs)
6.057000E-01
Normal-vs-Age(61-80Yrs)
6.676000E-01
Normal-vs-Age(81-100Yrs)
2.622600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.909800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.859800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.748400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.174800E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.423050E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.347800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.175200E-01
Normal-vs-Daily Drinker
9.561800E-01
Normal-vs-Weekly Drinker
9.127200E-01
Normal-vs-Occasional Drinker
9.419000E-01
Normal-vs-Social Drinker
8.401600E-01
Non Drinker-vs-Daily Drinker
9.065000E-01
Non Drinker-vs-Weekly Drinker
9.887200E-01
Non Drinker-vs-Occasional Drinker
7.050800E-01
Non Drinker-vs-Social Drinker
8.753400E-01
Daily Drinker-vs-Weekly Drinker
9.094000E-01
Daily Drinker-vs-Occasional Drinker
8.216800E-01
Daily Drinker-vs-Social Drinker
7.900600E-01
Weekly Drinker-vs-Occasional Drinker
7.595800E-01
Weekly Drinker-vs-Social Drinker
9.009600E-01
Occasional Drinker-vs-Social Drinker
6.001800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.132600E-01
Normal-vs-Grade 2
1.218050E-01
Normal-vs-Grade 3
1.439590E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.825900E-02
Grade 1-vs-Grade 3
7.055600E-03
Grade 1-vs-Grade 4
6.132600E-01
Grade 2-vs-Grade 3
2.647400E-01
Grade 2-vs-Grade 4
1.218050E-01
Grade 3-vs-Grade 4
1.439590E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.507400E-01
Normal-vs-NonDiabetic
9.575200E-01
Diabetic-vs-NonDiabetic
1.081200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.365000E-01
Normal-vs-NoPancreatitis
8.458200E-01
Pancreatitis-vs-NoPancreatitis
2.276300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.291600E-01
Normal-vs-N1
9.767000E-01
N0-vs-N1
1.167750E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.079400E-01
Normal-vs-TP53-NonMutant
4.322200E-01
TP53-Mutant-vs-TP53-NonMutant
5.205300E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
